Stock Events

Stock Events

Keros Therapeutics (KROS) Q2 2025 Earnings

6MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.41

0.27

1.94

3.62

Details

Expected EPS

-1.153528

Actual EPS

3.62

Surprise EPS

4.77

Surprise Percent

+413.82%

Description

Keros Therapeutics (KROS) has reported earnings of 3.62 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.